Increased chromosomal imbalances in recurrent pituitary adenomas

[1]  A. Franzin,et al.  Non‐random trisomies of chromosomes 5, 8 and 12 in the prolactinoma sub‐type of pituitary adenomas: Conventional cytogenetics and interphase fish study , 2000, International journal of cancer.

[2]  R. Simon,et al.  Chromosomal imbalances in primary lymphomas of the central nervous system. , 1999, The American journal of pathology.

[3]  S. Heim,et al.  Simple numerical chromosome aberrations characterize pituitary adenomas. , 1999, Cancer genetics and cytogenetics.

[4]  A. Hui,et al.  Detection of chromosomal imbalances in growth hormone-secreting pituitary tumors by comparative genomic hybridization. , 1999, Human pathology.

[5]  T. Okamura,et al.  Cytogenetic alterations in pituitary adenomas detected by comparative genomic hybridization. , 1999, Cancer genetics and cytogenetics.

[6]  J. Schramm,et al.  Analysis of the MEN1 gene in sporadic pituitary adenomas , 1999, The Journal of pathology.

[7]  F. Waldman,et al.  Multiple genetic aberrations including evidence of chromosome 11q13 rearrangement detected in pituitary adenomas by comparative genomic hybridization. , 1999, Journal of neurosurgery.

[8]  T. Sano,et al.  Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas. , 1998, The Journal of clinical endocrinology and metabolism.

[9]  R. Fahlbusch,et al.  Comparative genomic hybridization analysis of nonfunctioning pituitary tumors. , 1998, The Journal of clinical endocrinology and metabolism.

[10]  F. Collins,et al.  Mutations of the MEN1 tumor suppressor gene in pituitary tumors. , 1997, Cancer research.

[11]  M. Losa,et al.  Cytogenetic study of pituitary adenomas. , 1997, Cancer genetics and cytogenetics.

[12]  S. Melmed,et al.  Genetic basis of endocrine disease: pituitary tumor pathogenesis. , 1997, The Journal of clinical endocrinology and metabolism.

[13]  R. Thakker,et al.  Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. , 1997, The Journal of clinical endocrinology and metabolism.

[14]  B. Scheithauer,et al.  Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. , 1995, Cancer research.

[15]  G. Faglia,et al.  The role of the hypothalamus in pituitary neoplasia. , 1995, Bailliere's clinical endocrinology and metabolism.

[16]  D. Harrison,et al.  G‐protein mutations in human pituitary adrenocorticotrophic hormone‐secreting adenomas , 1995, European journal of clinical investigation.

[17]  N. Patronas,et al.  Pituitary Magnetic Resonance Imaging in Normal Human Volunteers: Occult Adenomas in the General Population , 1994, Annals of Internal Medicine.

[18]  R. Thakker,et al.  Molecular genetic studies of sporadic pituitary tumors. , 1994, The Journal of clinical endocrinology and metabolism.

[19]  E. Friedman,et al.  Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors. , 1993, The Journal of clinical endocrinology and metabolism.

[20]  J. Rock,et al.  Cytogenetic findings in pituitary adenoma: results of a pilot study. , 1993, Surgical neurology.

[21]  G. Rindi,et al.  Chromosome abnormalities in a case of pituitary adenoma. , 1993, Cancer genetics and cytogenetics.

[22]  S. Melmed,et al.  Molecular screening of pituitary adenomas for gene mutations and rearrangements. , 1993, The Journal of clinical endocrinology and metabolism.

[23]  R. Thakker,et al.  Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. , 1993, The Journal of clinical investigation.

[24]  E. Hedley‐Whyte,et al.  Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. , 1993, Journal of neurosurgery.

[25]  E. Hedley‐Whyte,et al.  Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. , 1992, The Journal of clinical endocrinology and metabolism.

[26]  E. Hedley‐Whyte,et al.  Ras mutations in human pituitary tumors. , 1992, The Journal of clinical endocrinology and metabolism.

[27]  E. Oldfield,et al.  Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. , 1991, The Journal of clinical endocrinology and metabolism.

[28]  K. Kovacs,et al.  Clonal origin of pituitary adenomas. , 1990, The Journal of clinical endocrinology and metabolism.

[29]  H. Bourne,et al.  Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. , 1990, The Journal of clinical endocrinology and metabolism.

[30]  C. Larsson,et al.  Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Giannattasio,et al.  Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas , 1987, Nature.